As a novel biotherapeutic agent, Akkermansia can induce the expression of mucins MUC2 and MUC3 [50], thereby preventing the adhesion of enteropathogenic Escherichia coli (EPEC) to the epithelium and improving health by regulating various metabolic disorders [51]. The gene discussed is MUC2; the disease is Other metabolic disease.